Galectin Therapeutics Inc. (GALT), a clinical-stage biotechnology company, on Monday published promising results from the Phase 2b NAVIGATE trial for belapectin in treating MASH cirrhosis and portal hypertension in AASLD flagship journal Hepatology. Metabolic dysfunction-related steatohepatitis (MASH)...
BridgeBio Pharma Inc. (BBIO), a commercial-stage biopharmaceutical company, on Monday announced new data from its Phase 3 ATTRibute-CM study of Acoramidis, demonstrating disease-modifying effects across clinical outcomes, biomarkers, and functional capacity in transthyretin amyloid cardiomyopathy. The...
WORK Medical Technology Group Ltd. (WOK), a supplier of medical devices in China, announced it has entered into a strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to jointly develop next-generation intelligent medical models.
Bicara Therapeutics Inc. (BCAX), a clinical-stage biopharmaceutical company, on Monday released the first quarter financial results and provided business updates for its lead candidate ficerafusp alfa. Q1 2026: The company received $161.8 million in net proceeds from an oversubscribed public offering...
Shares of Haoxi Health Technology Ltd (HAO) fell by about 93% following the announcement that the company has entered into a definitive agreement with investors for a $6.5 million registered direct offering.
Apyx Medical Corporation (APYX) announced that the U.S. FDA has granted expanded 510(k) clearance for its AYON Body Contouring System to include power liposuction capability.
Alvotech (ALVO) announced that the U.S. FDA has completed a routine cGMP surveillance inspection of its Reykjavik, Iceland manufacturing site. The inspection concluded on May 8, 2026, with the FDA issuing a Form 483.
Shares of Alpha Tau Medical Ltd. (DRTS) are up over 12% at $9.60 in premarket trading on Monday, following encouraging interim results from its U.S. Alpha DaRT recurrent glioblastoma trial, dubbed REGAIN.
iSpecimen Inc. (ISPC), an online marketplace for biospecimens, announced on Friday a private placement of 488,281 shares at $5.12 per share. The company is offering up to 488,281 shares of common stock at $5.12 per share. The offering is expected to close on May 11, 2026. In lieu of shares, iSpecimen...
Nexra Pharma Co., Ltd., (4565.T) announced progress in out-licensing a GPCR-targeted program and its participation in a Series A financing for NewCo, a new company co-founded with SV Health Investors.
MoonLake Immunotherapeutics Inc. (MLTX), a clinical-stage biopharmaceutical company, on Sunday, announced that its pre-BLA meeting with the FDA regarding its Hidradenitis suppurativa drug candidate sonelokimab yielded positive feedback, and it also reported financial results for the first quarter of...
argenx SE (ARGX) announced that the U.S. FDA has approved a label expansion for VYVGART (efgartigimod alfa-fcab) and VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized myasthenia gravis (gMG).
RadNet Inc. (RDNT), a diagnostic imaging company, on Sunday reported financial results for the first quarter and provided a revised 2026 update. The company specializes in fixed-site outpatient diagnostic imaging services with 235 imaging centers and develops digital health solutions. Q1 2026: The...
Longeveron Inc. (LGVN) on Friday announced it held a constructive Type C meeting with the U.S. FDA regarding its ongoing Phase 2b ELPIS II trial of laromestrocel (Lomecel-B) in hypoplastic left heart syndrome (HLHS).
iSpecimen Inc. (ISPC) Friday announced that it has priced a $2.5 million private placement with accredited investors. The financing involves the issuance of 488,281 shares of common stock at $5.12 per share, with certain investors receiving pre-funded warrants at $5.1199 per warrant in lieu of shares to manage ownership thresholds.
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.